S1PR2 and Hodgkins lymphoma: Clinical evaluation disclosed the first reported mixed HL in an affected individual, which suggests an expanded clinical outcome of individuals with mutations in S1PR2. Additionally, we model the identified amino acid residue exchange at the p.Arg108 position of S1PR2 and highlight the consequences of spatial disruption of this key amino acid with neighboring amino acid residues.